Literature DB >> 10577747

Clinical management of oral lichen planus.

C E McCreary1, B E McCartan.   

Abstract

Oral lichen planus is a relatively common chronic disease of the mucous membranes which may have more transient cutaneous manifestations. It has a number of well-recognized clinical signs and a wide range of symptoms from none through mild discomfort to severe debilitating intra-oral erosions and ulceration. It often does not respond to treatment and, in a small proportion of cases, undergoes malignant transformation to squamous cell carcinoma. Although there is an array of treatments, they are palliative rather than curative. Corticosteroids in various forms remain the mainstay of treatment but newer immunomodulatory agents have an increasing role. In this paper, we review current thinking about the management of oral lichen planus and summarize a recent European consensus protocol.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10577747     DOI: 10.1054/bjom.1999.0131

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  11 in total

1.  Detection of T cells secreting type 1 and type 2 cytokines in the peripheral blood of patients with oral lichen planus.

Authors:  F Kalogerakou; E Albanidou-Farmaki; A K Markopoulos; D Z Antoniades
Journal:  Hippokratia       Date:  2008       Impact factor: 0.471

2.  [Oral lichen planus. Insight into the pathogenesis and therapeutic options].

Authors:  M Hilgers; M Megahed
Journal:  Hautarzt       Date:  2014-05       Impact factor: 0.751

3.  [Pimecrolimus (Elidel) for therapy of lichen ruber mucosae].

Authors:  M Scheer; N Kawari-Mahmoodi; J Neugebauer; A C Kübler
Journal:  Mund Kiefer Gesichtschir       Date:  2006-11

4.  Evaluation of Efficacy of 1% Curcuminoids as Local Application in Management of Oral Lichen Planus - Interventional Study.

Authors:  Anju Elizabeth Thomas; Beena Varma; Seema Kurup; Renju Jose; Marina Lazar Chandy; Sreeja P Kumar; M S Aravind; Athira Aruna Ramadas
Journal:  J Clin Diagn Res       Date:  2017-04-01

5.  A comparative study of toluidine blue-mediated photodynamic therapy versus topical corticosteroids in the treatment of erosive-atrophic oral lichen planus: a randomized clinical controlled trial.

Authors:  Hasan Hoseinpour Jajarm; Farnaz Falaki; Majid Sanatkhani; Meysam Ahmadzadeh; Farzaneh Ahrari; Hooman Shafaee
Journal:  Lasers Med Sci       Date:  2014-12-09       Impact factor: 3.161

6.  A retrospective and comparative study of familial and non-familial bullous lichen planus.

Authors:  Changzheng Huang; Xiaofeng Yan; Lingyun Yang; Jing Zhang; Jin Tian; Jiawen Li; Chunsen Wang; Yating Tu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-06

7.  Bullous oral lichen planus: An unusual variant.

Authors:  Rashmi Jindal; Dipankar De; Amrinder J Kanwar
Journal:  Indian Dermatol Online J       Date:  2011-01

8.  Oral bullous lichen planus: Case report and review of management.

Authors:  Archana Patil; Shiva Prasad; L Ashok; G P Sujatha
Journal:  Contemp Clin Dent       Date:  2012-07

Review 9.  Systemic and Topical Steroids in the Management of Oral Mucosal Lesions.

Authors:  M Shashi Kiran; S Vidya; Gunjan Singh Aswal; Vinod Kumar; Vineet Rai
Journal:  J Pharm Bioallied Sci       Date:  2017-11

10.  Factors affecting treatment outcomes in patients with oral lichen planus lesions: a retrospective study of 113 cases.

Authors:  Shin-Young Park; Hyo-Jung Lee; So-Hyun Kim; Sung-Beom Kim; Yong-Hoon Choi; Young-Kyun Kim; Pil-Young Yun
Journal:  J Periodontal Implant Sci       Date:  2018-08-29       Impact factor: 2.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.